Bosch Health Campus Monthly Research Seminar
This seminar series features prominent speakers related to the various biomedical research foci within the Robert Bosch Gesellschaft für medizinische Forschung (RBMF), Dr. Margarete Fischer-Bosch Institut für Klinische Pharmakologie (IKP), Robert Bosch Centrum für Tumorerkrankungen (RBCT) and the Robert Bosch Centrum für Integrative Medizin und Gesundheit (RBIM).
2026
14.01.2026 Dr. Michael Zimmermann, Head of Metabolomics Core Facility Molecular Systems Biology Unit, EMBL, Heidelberg
Identifying gut microbial contributions to drug metabolism and carcinogen toxicity
23.02.2026 Jun.- Prof. Dr. Nieves Peltzer, Director of the Department Genome Editing, Institute of Biomedical Genetics / RNA Biology & Bioinformatics, University of Stuttgart
Reprogramming Cell Death Pathways to Enhance Anti-Tumor Immunity
02.03.2026 Prof. Shiv K. Singh, Group Leader, Transcriptional Reprogramming in Cancer Plasticity, University Medical Center Göttingen
Title tba
01.06.2026 Dr. Moritz Mall, Group Leader, Cell Fate Engineering and Disease Modeling, German Cancer Research Center, DKFZ, Heidelberg
Title tba